NASDAQ:ONCS
OncoSec Medical Incorporated
- Stock
Last Close
0.21
23/06 20:00
Market Cap
1.65M
Beta: 2.01
Volume Today
51.30M
Avg: 2.77M
PE Ratio
−0.02
PFCF: −0.07
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jul '13 | Jul '14 | Jul '15 | Jul '16 | Jul '17 | Jul '18 | Jul '19 | Jul '20 | Jul '21 | Jul '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||||
average payables | 556.70K - | 982.72K 76.52% | 618.18K 37.10% | 1.64M - | 1.64M 0% | ||||||
average receivables | |||||||||||
book value per share | 195.69 - | 879.07 349.21% | 565.98 35.62% | 373.71 33.97% | 116.55 68.81% | 125.70 7.85% | 75.73 39.75% | 18.46 75.63% | 25.46 37.95% | 3.42 86.55% | |
capex per share | -4.73 - | -11.83 150.20% | -24.77 109.34% | -20.66 16.61% | -0.23 98.86% | -0.36 52.05% | -0.03 91.37% | -0.53 - | -0.14 74.36% | ||
capex to depreciation | -0.16 - | -0.66 322.61% | -2.15 227.79% | -4.36 102.52% | -0.06 98.70% | -0.19 243.28% | -0.04 79.18% | -0.74 - | -0.23 69.04% | ||
capex to operating cash flow | 0.02 - | 0.06 175.66% | 0.08 42.07% | 0.09 7.37% | 0.00 98.57% | 0.00 125.64% | 0.00 87.86% | 0.02 - | 0.01 60.18% | ||
capex to revenue | |||||||||||
cash per share | 205.23 - | 874.10 325.90% | 554.55 36.56% | 382.95 30.94% | 124.71 67.43% | 147.92 18.62% | 78.44 46.97% | 27.08 65.47% | 30.72 13.45% | 6.88 77.59% | |
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | |||||||||||
debt to assets | 0.00 - | 0.26 9,238.43% | 0.13 50.31% | 0.28 117.04% | |||||||
debt to equity | 0.00 - | 0.56 16,252.44% | 0.19 65.93% | 1.01 425.11% | |||||||
dividend yield | 0.00 - | ||||||||||
earnings yield | -0.22 - | -0.14 35.95% | -0.28 92.51% | -0.88 220.81% | -1.03 16.57% | -0.79 23.74% | -1.92 144.70% | -0.61 68.39% | -0.63 3.49% | -1.17 85.52% | |
enterprise value | 27.00M - | 45.99M 70.34% | 44.98M 2.18% | 1.64M 96.35% | 9.35M 469.99% | 45.95M 391.40% | -9.34M 120.32% | 56.92M 709.68% | 33.10M 41.85% | 23.13M 30.10% | |
enterprise value over ebitda | -4.27 - | -4.12 3.49% | -2.19 46.90% | -0.06 97.17% | -0.44 617.76% | -1.42 219.24% | 0.31 122.16% | -1.35 529.22% | -0.70 48.08% | -0.64 7.95% | |
ev to operating cash flow | -4.88 - | -5.12 4.95% | -2.55 50.23% | -0.09 96.39% | -0.54 485.57% | -1.98 266.94% | 0.32 116.27% | -1.72 633.51% | -0.79 53.88% | -0.72 9.10% | |
ev to sales | |||||||||||
free cash flow per share | -233.21 - | -219.21 6.00% | -330.33 50.69% | -257.97 21.91% | -189.19 26.66% | -127.69 32.51% | -90.50 29.12% | -44.10 51.27% | -28.48 35.42% | -18.13 36.35% | |
free cash flow yield | -0.18 - | -0.11 35.91% | -0.25 118.82% | -0.64 157.20% | -0.83 31.01% | -0.47 43.94% | -1.84 294.11% | -0.48 74.13% | -0.59 24.41% | -1.11 86.39% | |
graham net net | 132.12 - | 843.53 538.45% | 324.95 - | 75.27 76.84% | 107.78 43.18% | 60.93 43.46% | 5.75 90.56% | 18.56 222.70% | -1.94 110.44% | ||
graham number | 1.14K - | 2.34K 105.43% | 2.16K 7.61% | 1.74K 19.80% | 782.90 54.89% | 779.03 0.49% | 401.13 48.51% | 152.79 61.91% | 131.53 13.92% | 38.40 70.81% | |
income quality | 0.77 - | 0.75 3.39% | 0.83 11.14% | 0.66 20.27% | 0.81 22.02% | 0.59 26.60% | 0.96 61.45% | 0.78 18.12% | 0.93 17.96% | 0.94 1.62% | |
intangibles to total assets | 0.18 - | 0.01 93.39% | 0 100% | 0 | 0 | 0 | 0 | 0 | 0.01 Infinity% | 0.02 117.13% | |
interest coverage | -84.90 - | -577.72 580.48% | -5.67 - | -7.99K 140,952.52% | -8.49K 6.18% | -3.05K 64.06% | -1.77K 42.03% | ||||
interest debt per share | 3.44 - | 0.48 86.10% | 34.93 - | 0.27 99.22% | 10.42 3,714.42% | 4.90 52.93% | 3.47 29.28% | ||||
inventory turnover | |||||||||||
invested capital | 0.00 - | 0.56 16,252.44% | 0.19 65.93% | 1.01 425.11% | |||||||
market cap | 31.97M - | 83.84M 162.27% | 77.02M 8.14% | 30.39M 60.55% | 20.80M 31.56% | 49.75M 139.25% | 15.73M 68.39% | 69.45M 341.52% | 71.73M 3.29% | 29.26M 59.21% | |
net current asset value | 3.40M - | 37.00M 988.40% | 25.06M - | 7.98M 68.17% | 21.30M 167.02% | 22.89M 7.49% | 6.79M 70.35% | 30.98M 356.34% | -527.49K 101.70% | ||
net debt to ebitda | 0.79 - | 3.39 331.48% | 1.56 54.06% | 1.08 30.40% | 0.54 49.87% | 0.12 78.41% | 0.84 618.73% | 0.30 64.81% | 0.82 175.30% | 0.17 79.12% | |
net income per share | -295.25 - | -277.38 6.05% | -367.73 32.57% | -358.20 2.59% | -233.73 34.75% | -214.59 8.19% | -94.43 55.99% | -56.22 40.47% | -30.20 46.28% | -19.13 36.65% | |
operating cash flow per share | -228.48 - | -207.38 9.24% | -305.56 47.34% | -237.31 22.33% | -188.95 20.38% | -127.33 32.61% | -90.47 28.95% | -44.10 51.25% | -27.94 36.64% | -17.99 35.63% | |
payables turnover | |||||||||||
receivables turnover | |||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -1.34 - | -0.31 76.92% | -0.60 93.43% | -0.83 39.01% | -1.41 69.71% | -1.29 8.11% | -1.01 21.72% | -1.41 39.51% | -0.81 42.74% | -1.59 96.50% | |
revenue per share | |||||||||||
roe | -1.51 - | -0.32 79.09% | -0.65 105.91% | -0.96 47.52% | -2.01 109.23% | -1.71 14.87% | -1.25 26.96% | -3.05 144.29% | -1.19 61.06% | -5.59 370.92% | |
roic | -1.49 - | -0.31 78.88% | -0.65 106.26% | -0.96 47.52% | -2.01 109.23% | -1.58 21.46% | -1.25 20.73% | -1.52 21.35% | -0.89 41.12% | -1.92 115.60% | |
sales general and administrative to revenue | |||||||||||
shareholders equity per share | 195.69 - | 879.07 349.21% | 565.98 35.62% | 373.71 33.97% | 116.55 68.81% | 125.70 7.85% | 75.73 39.75% | 18.46 75.63% | 25.46 37.95% | 3.42 86.55% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 3.58M - | 37.60M 951.14% | 28.05M - | 10.70M 61.87% | 22.92M 114.33% | 24.28M 5.91% | 13.87M 42.87% | 37.63M 171.28% | 5.74M 84.75% | ||
tangible book value per share | 147.72 - | 868.34 487.82% | 373.71 - | 116.55 68.81% | 125.70 7.85% | 75.73 39.75% | 18.46 75.63% | 25.16 36.32% | 3.21 87.23% | ||
working capital | 3.40M - | 37.00M 988.40% | 30.67M 17.09% | 25.95M 15.40% | 9.12M 64.87% | 22.77M 149.76% | 23.53M 3.33% | 13.14M 44.14% | 41.22M 213.59% | 8.60M 79.14% |
All numbers in USD (except ratios and percentages)